pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
  1. pharmadog
  2. ›drugs
  3. ›phenylbutyrate
drug · small molecule
save

phenylbutyrate

Phase 2updated 3mo ago
by Sunny Pharmtech Inc🔗 ChEMBL
Phase 2
community read0 votes

🐶 often sniffed alongside

top 8
  • tagApproval22 co-mentions · 6 sources
  • drugOLPRUVA14 co-mentions · 3 sources
  • tagSmall Molecule10 co-mentions · 5 sources
  • drugSodium phenylbutyrate Navinta8 co-mentions · 3 sources
  • drugSODIUM PHENYLBUTYRATE8 co-mentions · 3 sources
  • drugGLYCEROL PHENYLBUTYRATE3 co-mentions · 3 sources
  • companyNavinta LLC2 co-mentions · 1 sources
  • companyAurobindo Pharma Ltd1 co-mentions · 1 sources

Small molecule drug with a maximum clinical stage of Approval (across all indications), with 6 approved and 15 investigational indications.

all catalysts(0)

nothing on the calendar yet

Trials studying phenylbutyrate

  • phase2Study of Sodium Phenylbutyrate (ACER-001) for the Treatment of Pediatric and Adults Patients With Medium Chain Acyl-CoA Dehydrogenase Deficiency (MCADD)recruitingn=24
  • phase2Study of Sodium Phenylbutyrate (ACER-001) for the Treatment of Patients With Medium Chain Acyl-CoA Dehydrogenase Deficiency (MCADD)suspendedn=24
  • phase1An Individual Patient, Open Label Study to Use ACER-001 to Treat Combined D,L-2 Hydroxyglutaric Aciduria (C-2HGA)enrolling by invitationn=1

News(0)

no news has mentioned this drug yet

trade names
Ambutyrate, Ammonaps, Buphenyl, Olpruva, Pheburane, Sodium phenylbutyrate
generic
phenylbutyrate
indication
Chemotherapy Induced Oral Mucositis
phase
phase_2
Data sources
ClinicalTrials.gov · OpenTargets
last refreshed 33m ago
Found something off?
🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?